Table 2.

Adverse events after BNT162b2 vaccine in 78 pregnant women who received a second dose and 84 pregnant women who received a third (booster) dose.

Adverse Event	Second Vaccination (n = 78)	Third Vaccination (n = 84)	p Value
Rash/Local pain/Local swelling	73 (93.6%)	61 (72.6%)	<0.001
Gastrointestinal symptoms	13 (16.7%)	8 (9.5%)	0.176
Fever (37.5 and up)	7 (9.0%)	8 (9.5%)	0.579
Weakness and fatigue	45 (57.7%)	32 (38.1%)	0.013
Myalgia	21 (26.9%)	17 (20.2%)	0.316
Axillary lymphadenopathy	2 (2.6%)	6 (7.1%)	0.179
Remote lymphadenopathy	3 (3.8%)	7 (8.3%)	0.236
Paresthesia	4 (5.1%)	4 (4.8%)	0.914
Headache	5 (6.4%)	3 (3.6%)	0.405
Bell’s palsy	0 (0%)	0 (0%)	N/A
Myocarditis	0 (0%)	0 (0%)	N/A
Anaphylaxis	0 (0%)	0 (0%)	N/A
Hospitalization	0 (0%)	0 (0%)	N/A
Uterine Contractions	1 (1.3%)	3 (3.6%)	0.348
Vaginal Bleeding	0 (0%)	0 (0%)	N/A
PPROM	0 (0%)	0 (0%)	N/A

Data are given as n (%). N/A, not applicable. PPROM—preterm premature rapture of membranes.